Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Hinxton

AI x BIO Conference

This event will explore best practices for the clinical application of genomic data, focusing on variant interpretation, clinical utility, and the development of consensus-curated knowledge. [...]

Hinxton

Molecular Neurodegeneration and Therapeutic Approaches

This well-established course offers a comprehensive introduction to the clinical features of several major neurodegenerative diseases, including Alzheimer’s, Huntington’s, Parkinson’s, amyotrophic lateral sclerosis (ALS), frontotemporal [...]

Hinxton

Evolutionary Biology and Ecology of Cancer

Cancer behaves as a dynamic ecosystem of constantly evolving cells, making evolutionary and ecological principles essential to both understanding its behaviour and informing clinical strategies. [...]

Hinxton

Methods for infectious disease modelling using genomics

This EMBO Practical Course offers a comprehensive introduction to the principles, tools, and techniques of infectious disease modelling, with a special focus on integrating genomic [...]

Hinxton

CRISPR Screening and Analysis

CRISPR screening, both pooled and arrayed, offers powerful tools for research and clinical discovery. While arrayed screening focuses on targeted gene editing to study specific [...]

Hinxton

Mitochondrial Medicine – Therapeutic Development

Mitochondrial disorders are now recognised as a significant cause of inherited disease. Progress toward new treatments relies on strong collaboration between clinicians, lab-based researchers, and [...]

Go to Top